TriSalus Life Sciences Inc. (NASDAQ: TLSI) Stock Information | RedChip

TriSalus Life Sciences Inc. (NASDAQ: TLSI) Listen to this Section


$5.60
+0.0300 ( +0.54% ) 24.3K

TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.

Market Data


Open


$5.60

Previous close


$5.57

Volume


24.3K

Market cap


$202.07M

Day range


$5.53 - $5.68

52 week range


$3.32 - $16.24

Insider Ownership Transactions

Total Amount Purchased: -358,943.00 | $ -2,010,080.80

Date Type Amount Purchased Purchaser
2024-07-02 Sale -74000.00 Desai Arjun JJ
2024-06-05 Sale -35000.00 VON ESCHENBACH ANDREW C.
2024-05-07 Sale -35000.00 Hyveled Liselotte
2024-02-14 Sale -17500.00 Devlin Jodi
2024-02-14 Sale -34144.00 Katz Steven C
2024-02-14 Sale -84899.00 Szela Mary T
2024-02-14 Sale -14752.00 Marshak Richard
2024-02-14 Sale -34144.00 Murphy Sean
2024-02-14 Sale -14752.00 Cox Bryan F.
2024-02-14 Sale -14752.00 Stevens Jennifer

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 15, 2024
10-q Quarterly Reports 88 Aug 14, 2024
def Proxies and info statements 14 Jul 19, 2024
ars Annual reports 1 Jul 19, 2024
4 Insider transactions 1 Jul 02, 2024
8-k 8K-related 15 Jul 01, 2024
8-k 8K-related 16 Jun 27, 2024
4 Insider transactions 1 Jun 05, 2024
8-k 8K-related 15 May 24, 2024
3/a Insider transactions 1 May 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.